A video worth knowing

Hank Green explains the lure of the "Theranos trap"

Blood-test chemistry and a conversation with whistleblower Tyler Shultz explain why a simpler healthcare story can be so persuasive.

Channel:

Hank Green Story of October 24, 2026Trari Newsroom

No. 9 on the Science chart

Why this story? 3,220,430 views so far, and here is what is inside it.

The Theranos Trap

Things we can learn from the video

Press to jump

7:27Electrical changes let laboratory instruments count blood cells and measure their size.
11:12Different collection tubes contain additives suited to different tests; one preparation cannot serve every purpose.
21:22Green explains how Theranos diluted finger-prick samples and processed them on commercial analyzers.
25:45The title's trap: frustration with healthcare can make simplistic promises seem more credible than complex realities.
40:00Shultz argues that selling diagnostic information is difficult when customers may receive problems rather than solutions.
52:43Shultz describes Edison's robotic pipette mechanism and failures in supporting equipment.

Those different-colored caps on blood collection tubes aren't just a filing system. They help explain why Theranos's promise was so much harder than it sounded, and why Hank Green spends much of "The Theranos Trap" showing what ordinary laboratories already accomplish.

His central argument is about more than a failed machine: frustration with expensive, complicated healthcare can make a beautifully simple alternative seem believable. Green calls that the trap. If people assume existing systems are complicated only because the people running them are terrible, they can miss the genuine scientific reasons something is difficult.

The explanation gets satisfyingly specific. Blood contains cells, platelets and plasma, and different tests need different preparations. An additive that preserves a sample for counting cells can make it unsuitable for measuring something else. As Green puts it: "The blood that went into the complete blood count vial is chemically ruined for many tests the moment it goes in that tube."

He also explains why consecutive drops from a finger prick can vary, and describes how Theranos diluted tiny samples to run them on commercial laboratory equipment rather than delivering its promised all-in-one technology.

The 84-minute video then brings in former Theranos employee and whistleblower Tyler Shultz. He describes the Edison device as a robotic pipette system using established immunoassay chemistry, a considerably less revolutionary reality than the company's pitch. Their conversation also examines a commercial difficulty: diagnostic testing can sell people news of a problem, not a solution they want to buy.

The video has reached roughly 3.2 million views. In the comments, laboratory workers repeatedly pick up on something less glamorous than the Theranos story: the skilled, largely unseen work behind an everyday blood-test result.

Published on Trari